Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial

Nasser A. Dhayat(University of Bern), Daniel G. Fuster(University of Bern), Luca Gabutti(University Hospital of Bern), Olivier Bonny, Beat Roth(University Hospital of Bern), Michael Mayr(University of Basel), Irene Koneth(University of St.Gallen), Luca Tamò(University of Bern), Thomas Ernandez(University of Geneva), Nilufar Mohebbi(University Hospital of Zurich), Alexander Ritter(University of St.Gallen), Bruno Vogt(Hypertension Institute), Sven Trelle(Institute of Social and Preventive Medicine), Urs Odermatt(University Hospital of Bern), Catherine Stoermann-Chopard(University of Geneva), Felix Rintelen(University of Bern), Florian Buchkremer(Kantonsspital Aarau), Marie Roumet(University Hospital of Bern), Daniel Teta(University Hospital of Bern), Irina Irincheeva(University of Bern), Giulia Bedino(University Hospital of Bern), Carlo Schönholzer(Ospedale regionale di Lugano), Patrizia Amico(University of Basel), Carina Hüsler(University of St.Gallen), Lisa Pellegrini(University Hospital of Bern), Rosaria Del Giorno(Ente Ospedaliero Cantonale), Reto Venzin, Nicolas Faller(University Hospital of Bern)
BMC Nephrology
December 1, 2018
Cited by 33


Related Papers